Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

British contract research firms fight to find science talent

Our CSO, Gareth Jenkins, recently discussed the growing success of CROs and CDMOs in the UK. The C&EN article provides insights into Arcinova's recruitment strategy as the pharmaceutical industry increasingly relies on outsourcing for drug development.

Read the article here

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.